Lu Lucy 4
4 · AVENUE THERAPEUTICS, INC. · Filed Jun 5, 2019
Insider Transaction Report
Form 4
Lu Lucy
DirectorPresident, CEO
Transactions
- Award
Restricted Stock Units
2019-06-03+135,617→ 135,617 totalExercise: $0.00Exp: 2024-06-03→ Common Stock (135,617 underlying)
Footnotes (1)
- [F1]Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.